Regenxbio Market Sentiment

Regenxbio Inc

RGNXNASDAQ

Trade with Public

$7.43

0.010.13%

Dern. MÀJ: Oct 2, 7:24 PM

$7.48

0.060.81%

Aperçu Actualités Prévisions de résultats Événements Objectifs de cours Données financièresSentimentActionnariat Comparer Options Rapport sur les stocks

Regenxbio Market Sentiment - Benzinga

Regenxbio Market Sentiment

Market sentiment signals for Regenxbio (RGNX): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus— Outperform

Short Interest▼ 12.7% short float

Options Flow▼ 1.96 P/C ratio

Insider Activity— N/A

Analyst Consensus

Outperform

14 analysts

Options Flow (P/C)

1.96

More puts — Bearish

617 calls · 1,208 puts

Avg Consensus PT

$24

+218.0%

Highest Price Target

$50

+568.4%

Chardan Capital

Lowest Price Target

$12

+60.4%

Barclays

Short Interest

12.7%

Rising — Bearish

Insider Activity (30d)

—

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Aug 25, 2026	HC Wainwright & Co.	Yi Chen—	+180.7%	$23 → $21	Maintained	Buy
Aug 25, 2026	Baird	Brian Skorney—	+287.7%	$32 → $29	Maintained	Outperform
Aug 10, 2026	HC Wainwright & Co.	Yi Chen—	+207.5%	$26 → $23	Maintained	Buy
Aug 7, 2026	Barclays	Eliana Merle—	+60.4%	$12 → $12	Downgrade	Overweight→Equal-Weight
Jun 24, 2026	HC Wainwright & Co.	Yi Chen—	+247.6%	$26 → $26	Maintained	Buy
Jun 22, 2026	Baird	Brian Skorney—	+327.8%	$27 → $32	Maintained	Outperform
Jun 22, 2026	Leerink Partners	Mani Foroohar—	+140.6%	$17 → $18	Maintained	Outperform
Jun 5, 2026	HC Wainwright & Co.	Yi Chen—	+247.6%	$30 → $26	Maintained	Buy
May 15, 2026	B of A Securities	Geoff Meacham—	+87.2%	$25 → $14	Maintained	Buy
May 15, 2026	Barclays	Gena Wang—	+60.4%	$37 → $12	Maintained	Overweight
Mar 9, 2026	HC Wainwright & Co.	Yi Chen—	+301.1%	$32 → $30	Maintained	Buy
Mar 6, 2026	Morgan Stanley	Judah Frommer—	+127.3%	$18 → $17	Maintained	Overweight
Feb 10, 2026	HC Wainwright & Co.	Yi Chen—	+327.8%	$34 → $32	Maintained	Buy
Feb 10, 2026	Goldman Sachs	Paul Choi—	+60.4%	$14 → $12	Maintained	Neutral
Feb 10, 2026	Morgan Stanley	Judah Frommer—	+140.6%	$25 → $18	Maintained	Overweight
Feb 10, 2026	Chardan Capital	Daniil Gataulin—	+568.4%	$52 → $50	Maintained	Buy
Jan 29, 2026	Chardan Capital	Daniil Gataulin—	+595.2%	$52 → $52	Maintained	Buy
Dec 19, 2025	Stifel	Annabel Samimy—	+501.6%	$40 → $45	Maintained	Buy
Dec 15, 2025	Leerink Partners	Mani Foroohar—	+167.4%	$16 → $20	Maintained	Outperform
Nov 20, 2025	Chardan Capital	Daniil Gataulin—	+595.2%	$52 → $52	Maintained	Buy
Nov 7, 2025	RBC Capital	Luca Issi—	+154.0%	$17 → $19	Maintained	Outperform
Oct 7, 2025	HC Wainwright & Co.	Yi Chen—	+354.5%	$34 → $34	Maintained	Buy
Sep 8, 2025	HC Wainwright & Co.	Yi Chen—	+354.5%	$34 → $34	Maintained	Buy
Sep 8, 2025	Chardan Capital	Daniil Gataulin—	+595.2%	$52 → $52	Maintained	Buy
Aug 19, 2025	HC Wainwright & Co.	Yi Chen—	+354.5%	$34 → $34	Maintained	Buy